WS #1013

The dominant signal in this data window is a significant escalation in Middle East geopolitical tensions, with breaking reports of Iranian missiles striking Tel Aviv and Lyd, including impacts near Ben Gurion Airport. This event, corroborated by a jetstream priority alert, directly follows earlier reports of drone attacks on Dubai International Airport, amplifying regional instability. Concurrently, Bank of America projects Brent crude could average $130/barrel if the conflict extends into the second half of the year, with U.S. crude futures already falling over $4 to an intra-day low of $94.31 per barrel, indicating immediate market stress. These developments are highly actionable for energy markets and broader risk sentiment, overshadowing routine corporate filings and analyst ratings. In corporate developments, Ondas Inc. has completed the full acquisition of 4M Defense, acquiring the remaining 30% stake using shares, which could impact its stock and the defense sector. Structure Therapeutics' Phase 2 trial for its oral obesity drug aleniglipron shows up to 16.3% placebo-adjusted weight loss, rivaling injectables and potentially affecting obesity treatment stocks like GPCR, VKTX, NVO, and LLY. Additionally, OpenAI is in advanced talks with private equity firms like TPG and Bain Capital for a joint venture worth up to $10 billion, as reported by Reuters, signaling major AI infrastructure investments that could influence AI-related stocks such as NVDA and META. These events are likely to drive specific ticker movements in the next 1-8 hours.